Rekordhoch: Gold bei 3.000 $! Jetzt in physisches Gold investieren - mit philoro. Zum Goldshop

Edwards Lifesciences Aktie

NeuKaufen Kaufen Verkaufen Verkaufen

Aktien-Sparplan anlegen Aktien-Sparplan anlegen

63,70 EUR +1,19 EUR +1,90 %

14.03.2025

STU

69,25 USD +1,29 USD +1,90 %

nachbörslich14.03.2025

BTT

Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!

JETZT LOSLEGEN

Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handeln Smartphone

Marktkap.37,12 Mrd. EUR

KGV31,67Div. Rendite0,00%

WKN936853

ISINUS28176E1082

SymbolEW

Edwards Lifesciences Aktien News

Sortieren:Datum Meistgelesen

17.05.23PR NewswireDATA FROM BENCHMARK REGISTRY DEMONSTRATE IMPROVED TAVR EFFICIENCY WITH PRESERVED PATIENT SAFETY

08.05.23PR NewswireEDWARDS' AORTIC VALVE WITH RESILIA TISSUE SHOWS FAVORABLE DURABILITY, SAFETY AND EFFICACY OUTCOMES IN SEVEN YEAR DATA

26.04.23PR NewswireEDWARDS LIFESCIENCES REPORTS FIRST QUARTER RESULTS

19.04.23PR NewswireEDWARDS LIFESCIENCES TO HOST EARNINGS CONFERENCE CALL ON APRIL 26, 2023

06.03.23PR NewswireEDWARDS HIGHLIGHTS NEW DATA AT ACC RELATED TO LIFETIME MANAGEMENT OF AORTIC STENOSIS

31.01.23PR NewswireEDWARDS LIFESCIENCES REPORTS FOURTH QUARTER RESULTS

24.01.23PR NewswireEDWARDS LIFESCIENCES TO HOST EARNINGS CONFERENCE CALL ON JANUARY 31, 2023

05.01.23PR NewswireEDWARDS LIFESCIENCES TO PRESENT AT THE 41ST ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

08.12.22PR NewswireEDWARDS LIFESCIENCES OUTLINES GROWTH STRATEGY AT ANNUAL INVESTOR CONFERENCE

08.12.22PR NewswireEDWARDS LIFESCIENCES ANNOUNCES CEO SUCCESSION PLAN

27.11.22PR NewswireEDWARDS ANNOUNCES ONE-YEAR DATA ON TRANSFEMORAL TRANSCATHETER TRICUSPID VALVE REPLACEMENT

08.11.22RSSForm 4 1099800

28.10.22RSSForm 10-Q 1099800

27.10.22PR NewswireEDWARDS LIFESCIENCES REPORTS THIRD QUARTER RESULTS

27.10.22RSSForm 8-K 1099800

20.10.22PR NewswireEDWARDS LIFESCIENCES TO HOST EARNINGS CONFERENCE CALL ON OCTOBER 27, 2022

11.10.22RSSStatement of changes in beneficial ownership of securities

17.09.22PR NewswireEDWARDS ANNOUNCES SIX-MONTH DATA CONFIRMING TEER AS SAFE AND EFFECTIVE FOR DMR IN FIRST HEAD-TO-HEAD TRIAL

15.09.22PR NewswireEDWARDS PASCAL PRECISION TRANSCATHETER VALVE REPAIR SYSTEM RECEIVES FDA APPROVAL FOR DEGENERATIVE MITRAL REGURGITATION

12.09.22PR NewswireEDWARDS LAUNCHES SAPIEN 3 ULTRA RESILIA VALVE FOLLOWING FDA APPROVAL

17.08.22PR NewswireEDWARDS PASCAL PRECISION TRANSCATHETER MITRAL AND TRICUSPID VALVE REPAIR SYSTEM RECEIVES CE MARK

28.07.22PR NewswireEDWARDS LIFESCIENCES REPORTS SECOND QUARTER RESULTS

22.07.22RSSAutomatic shelf registration statement of securities of well-known seasoned issuers

21.07.22PR NewswireEDWARDS LIFESCIENCES TO HOST EARNINGS CONFERENCE CALL ON JULY 28, 2022

23.05.22PR NewswireEDWARDS LIFESCIENCES TO PRESENT AT THE BERNSTEIN 38TH ANNUAL STRATEGIC DECISIONS CONFERENCE

16.05.22PR NewswireEDWARDS ANNOUNCES KEY EVENTS FOR EUROPCR 2022

10.05.22RSSStatement of changes in beneficial ownership of securities

05.05.22RSSInitial statement of beneficial ownership of securities

04.05.22RSSInitial statement of beneficial ownership of securities

28.04.22RSSForm 4 1099800

28.04.22RSSForm 10-Q 1099800

26.04.22PR NewswireEDWARDS LIFESCIENCES REPORTS FIRST QUARTER RESULTS

19.04.22PR NewswireEDWARDS LIFESCIENCES TO HOST EARNINGS CONFERENCE CALL ON APRIL 26, 2022

11.04.22RSSForm 4 1099800

05.04.22RSSForm 4 1099800

31.03.22PR NewswireEDWARDS MITRIS RESILIA VALVE RECEIVES FDA APPROVAL FOR MITRAL REPLACEMENT SURGERIES

22.03.22RSSForm DEFA14A 1099800

Edwards Lifesciences News

Edwards Lifesciences News: auf dieser Seite finden Sie alle Edwards Lifesciences News und Nachrichten zur Edwards Lifesciences Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Edwards Lifesciences News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Edwards Lifesciences News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.